|
Model Number VP556X-2 |
Device Problems
Break (1069); Unraveled Material (1664)
|
Patient Problems
Wound Dehiscence (1154); Hematoma (1884)
|
Event Date 11/16/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
D10 concomitant products: vp706x-2, srgproii 6-0 30 bl cv-11 da vp706x-2, (lot #d1c0719y) vp706x-2, srgproii 6-0 30 bl cv-11 da vp706x-2, (lot #d2l2537y) medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, following a vascular surgery, a complication occurred when three sutures were accidentally cut during the surgeon's attempt to repair the arteries.An operation was conducted a week later, revealing a large hematoma at the surgical site, confirming suture dehiscence as the cause, an occurrence unfamiliar to the surgeon.The patient experienced complications a week after the initial surgery.Fortunately, the patient was still hospitalized, preventing what could have been a tragedy had they been discharged.The event led to an extension of the patient's hospitalization.
|
|
Manufacturer Narrative
|
H6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was not returned, but five photos were available for evaluation.The evaluation found no potentially contributing factors.It was reported that the suture broke and the suture line did not hold.The reported issues could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|